|
|
| September 26, 2019: Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibi |
Dr. Dean Kereiakes and Dr. C. Michael Gibson Discuss: First Human Use of a Novel
Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care
Treatment
TBD
[ Download video ] |
|
No comments have been submitted
|